A new systematic review of 20 observational studies suggests that hair dye exposure during pregnancy may be associated with adverse outcomes including low birth weight, stillbirth, and certain childhood cancers, though researchers emphasize the evidence remains preliminary and causal links have not been established. The findings, published in September 2026, highlight a significant gap in our understanding of cosmetic chemical safety during one of the most vulnerable periods of human development.

What Does the Research Actually Show About Hair Dyes and Pregnancy?

Researchers from the University of Verona conducted a comprehensive search of medical databases through August 2024, reviewing 311 records and ultimately analyzing 20 studies that examined the relationship between hair dye exposure during the periconceptional period (around the time of conception) or during pregnancy and health outcomes in newborns and children. The meta-analysis found several concerning associations, though the certainty of the evidence was rated as low to very low.

The pooled analysis revealed that periconceptional or pregnancy hair dye exposure was associated with a 2.3-fold increased risk of low birth weight compared to no exposure. Additionally, researchers found associations with stillbirth, reduced hormone levels in mothers, and several childhood conditions in offspring, including allergic rhinitis, leukemia, and neuroblastoma, which showed a 1.79-fold increased risk. The study also identified potential links to Wilms tumor and germ cell tumors, though the number of studies examining these outcomes was limited.

Notably, the analysis found no significant associations between hair dye exposure and childhood asthma, brain tumors, or intellectual disability, suggesting that not all potential health effects show consistent evidence of harm.

Why Is This Study Important If the Evidence Is Still Uncertain?

The researchers acknowledge a critical limitation: most of the included studies were retrospective, meaning participants recalled their hair dye use after pregnancy had already occurred, which can introduce memory errors and bias. The authors emphasize that their findings are "hypothesis-generating" rather than proof of causation. Despite these limitations, the review highlights a troubling gap in safety research, particularly given how common hair dyeing is among women of childbearing age.

More than one-third of women over 18 in Europe and the United States use some type of hair dye. As women delay childbearing to later ages, the proportion of pregnant women exposed to hair dyes during the periconceptional period has increased substantially. This demographic shift makes understanding the safety profile of these products increasingly urgent.

The heterogeneity of hair dye products complicates the picture. Hair dyes vary significantly in their chemical composition and potential toxicity based on their origin and how long they last on the hair. Understanding which specific dyes or chemicals pose the greatest risk remains an open question.

What Chemicals in Hair Dyes Should Pregnant People Know About?

Hair dyes are classified into several categories based on their chemical composition and durability. The most concerning category appears to be permanent dyes, which rely on synthetic chemicals to achieve lasting color change. The primary active ingredient in permanent dyes is p-phenylenediamine, commonly abbreviated as PPD, an aromatic amine that has demonstrated toxicological properties in laboratory studies.

PPD works by penetrating deep into the hair cortex through an oxidative process, and research has shown it can induce cell death by increasing reactive oxygen species, a form of cellular damage. Critically, PPD can penetrate the skin or be absorbed through inhalation, meaning exposure occurs not just through direct contact but also through breathing in fumes during application.

In contrast, semipermanent and temporary dyes present a lower absorption risk. Semipermanent dyes contain low-molecular-weight molecules that penetrate only superficially into the hair cortex without oxidative processing, while temporary dyes consist of large molecules that deposit only on the hair surface and wash out within a few applications. Some mineral or metallic dyes, however, are recognized as potentially toxic despite their temporary nature.

Plant-based dyes, such as henna, chamomile, and quinine, are classified as nontoxic and fade quickly from the hair. These represent the lowest-risk option for individuals concerned about chemical exposure during pregnancy.

How to Reduce Hair Dye Exposure During Pregnancy

• Choose Lower-Risk Dye Types: If hair coloring is desired during pregnancy, semipermanent or temporary dyes present lower absorption risks than permanent dyes containing PPD. Plant-based options like henna offer the lowest chemical exposure, though results may differ from synthetic dyes.
• Limit Application Frequency: Reducing how often hair dyes are applied during pregnancy decreases cumulative chemical exposure. Consider extending the time between coloring sessions or waiting until after the first trimester when fetal organ development is less active.
• Ensure Proper Ventilation: Apply hair dyes in well-ventilated spaces to minimize inhalation of chemical fumes. Open windows, use exhaust fans, or apply dyes outdoors when possible to reduce airborne exposure.
• Use Protective Barriers: Wear gloves during application to prevent skin absorption of PPD and other chemicals. Avoid getting dye on the scalp, which has higher absorption rates than other skin areas.
• Consult Your Healthcare Provider: Pregnant individuals should discuss hair coloring plans with their obstetrician or midwife, who can provide personalized guidance based on individual risk factors and pregnancy stage.

What Do Public Health Agencies Currently Recommend?

Current guidance from major public health organizations, including the United Kingdom's National Health Service (NHS), generally conveys a reassuring message about hair dye safety during pregnancy. The NHS acknowledges that while exposure to high doses of certain chemicals could be harmful, the concentrations present in commercial hair dyes are emphasized as minimal. The agency recommends standard precautions including wearing gloves, limiting application time, and ensuring proper ventilation.

However, this reassurance is tempered by an important caveat: the NHS itself acknowledges the limited scope of available research on which these recommendations are based. The disconnect between public health messaging and the actual state of scientific evidence underscores the need for more rigorous, prospective studies that follow pregnant women forward in time rather than relying on recalled exposure.

Notably, a separate meta-analysis examining reproductive health among professional hairdressers identified associations with adverse reproductive and obstetric outcomes, suggesting that occupational exposure to hair dyes at higher concentrations may carry greater risks than consumer use. This finding hints that dose and duration of exposure likely matter significantly.

What Happens Next in Hair Dye Safety Research?

The authors of the systematic review call for prospective studies that follow pregnant women forward through their pregnancies and into their children's lives, rather than asking them to recall exposure after the fact. Such studies would allow researchers to document exposure timing, specific dye types used, and application frequency with greater accuracy. Additionally, future research should distinguish between different types of hair dyes and specific chemicals, since the current evidence lumps all dyes together despite their vastly different chemical profiles.

Understanding which specific chemicals drive any observed associations would allow for more targeted safety recommendations and could inform regulatory decisions about which ingredients should be restricted or banned in consumer products. Until such evidence emerges, pregnant individuals and those planning pregnancy face uncertainty about whether to continue a cosmetic practice that has become routine for millions of women.

The gap between current public health reassurance and the preliminary evidence of potential harm illustrates a broader challenge in cosmetic safety: many products used by millions of people have never been rigorously studied in vulnerable populations like pregnant women. Closing this evidence gap will require sustained research investment and a willingness to update safety guidance as new data emerges.